| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/26/2002 | WO2002074241A2 Method of delaying ejaculation |
| 09/26/2002 | WO2002074238A2 Water soluble and palatable complexes |
| 09/26/2002 | WO2002074236A2 Skin whiteners containing hydroxytetronic acid |
| 09/26/2002 | WO2002074235A2 Heterocyclic compounds for therapeutic use |
| 09/26/2002 | WO2002074232A2 Antitumor compositions containing taxane derivatives |
| 09/26/2002 | WO2002074231A2 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata |
| 09/26/2002 | WO2002074229A2 A combination comprising combretastatin and anticancer agents |
| 09/26/2002 | WO2002074228A2 Pharmaceutical composition for the treatment of diabetes comprising a 5-phenoxyalkal-2,4-thiazolidinedione derivative and a compound that stimulates insulin secretion |
| 09/26/2002 | WO2002074200A1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 09/26/2002 | WO2002074158A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | WO2002074099A2 Polybutene containing chewing gum and confection |
| 09/26/2002 | WO2002074056A2 Allosteric adenosine receptor modulators |
| 09/26/2002 | WO2002074050A2 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 09/26/2002 | WO2002074048A2 P-glycoproteins and uses thereof |
| 09/26/2002 | WO2002074042A2 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 09/26/2002 | WO2002074036A2 Substituted benzopyranones as telomerase inhibitors |
| 09/26/2002 | WO2002074034A2 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 09/26/2002 | WO2002062780A3 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 09/26/2002 | WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof |
| 09/26/2002 | WO2002060455A8 Methods and compositions utilizing 2'-5' oligoadenylates in the treatment of disorders of cell proliferation |
| 09/26/2002 | WO2002060382A3 Novel compounds and uses thereof |
| 09/26/2002 | WO2002058638A3 Serpin drugs for treatment of hiv infection and method of use thereof |
| 09/26/2002 | WO2002056755A3 Method for treating cancer |
| 09/26/2002 | WO2002055517A3 4-(hetero)aryl substituted indolinones |
| 09/26/2002 | WO2002055064A3 Mucopolysaccharidosis therapies |
| 09/26/2002 | WO2002053108A3 Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package |
| 09/26/2002 | WO2002051431A9 Therapeutic and/or preventive agents for diseases due to retinal ischemia |
| 09/26/2002 | WO2002049635A3 Use of 5-aminolevulinic acid for the prophylaxis of restenosis |
| 09/26/2002 | WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/26/2002 | WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 09/26/2002 | WO2002043566A3 Devices and methods for treating low blood sugar levels |
| 09/26/2002 | WO2002040487A3 Benzodiazepine derivatives as gaba a receptor modulators |
| 09/26/2002 | WO2002040484A3 Novel imidazole derivatives, production method thereof and use thereof |
| 09/26/2002 | WO2002038544A3 3-substituted oxindole beta 3 agonists |
| 09/26/2002 | WO2002036167A8 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/26/2002 | WO2002036116A3 Tripeptidyl peptidase inhibitors |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation |
| 09/26/2002 | WO2002030922A3 Dioxolane analogs for improved inter-cellular delivery |
| 09/26/2002 | WO2002030421A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/26/2002 | WO2002028810A3 Retinoids for the treatment of emphysema |
| 09/26/2002 | WO2002028180A3 Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof |
| 09/26/2002 | WO2002026277A3 Stabilized hydrogen peroxide solutions |
| 09/26/2002 | WO2002024692A8 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 09/26/2002 | WO2002024685A8 Indole derivatives and their use as antifungal and/or antiparasitic agents |
| 09/26/2002 | WO2002024666A3 4-amino-quinazolines |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2002024174A3 Sustained release composition containing clarithromycin |
| 09/26/2002 | WO2002022645A3 Method of making 7alpha-methyl-11beta-methoxy estradiol and related compounds with estrogenic activity |
| 09/26/2002 | WO2002018941A3 Screen for glutamate reuptake inhibitors, stimulators, and modulators |
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | WO2002004439A3 Thiophene retinoids |
| 09/26/2002 | WO2002003975A3 Combinations of ssri and estrogenic agents |
| 09/26/2002 | WO2001098317A3 Alpha-glycosylceramides for treating bacterial and fungal infections |
| 09/26/2002 | WO2001091756A3 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders |
| 09/26/2002 | WO2001090159B1 Compositions and methods for delivery of a molecule into a cell |
| 09/26/2002 | WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 09/26/2002 | WO2001085093A9 Compounds and methods for modulating cerebral amyloid angiopathy |
| 09/26/2002 | WO2001080837A2 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 09/26/2002 | WO2001076635A1 Preparations for preventing bile acid diarrhea |
| 09/26/2002 | WO2001076568A3 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 09/26/2002 | WO2001074338A1 Transdermal therapeutic system for the delivery of lerisetron |
| 09/26/2002 | WO2001074331A1 Oily compositions containing highly fat-soluble drugs |
| 09/26/2002 | WO2001073002A3 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 09/26/2002 | WO2001072743A1 Triazole compounds having amide linkage |
| 09/26/2002 | WO2001072695A1 Neovascularization inhibitors |
| 09/26/2002 | WO2001070206B1 Combination of lecithin with ascorbic acid |
| 09/26/2002 | WO2001052847A8 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 09/26/2002 | WO2001051051B1 AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS |
| 09/26/2002 | WO2001034119A9 Inhibitors of crystallization in a solid dispersion |
| 09/26/2002 | WO2001032156A3 Methods for treating fibroproliferative diseases |
| 09/26/2002 | WO2001019823A9 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 09/26/2002 | WO2001015744A9 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 09/26/2002 | WO2000074634A9 Methods and compositions for modulating cell proliferation and cell death |
| 09/26/2002 | WO2000061112A3 Solubilized pharmaceutical composition for parenteral administration |
| 09/26/2002 | WO2000027868A9 Connective tissue growth factor (ctgf) and methods of use |
| 09/26/2002 | WO1998004246A3 Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020138874 Elongase genes and uses thereof |
| 09/26/2002 | US20020138032 Treating chronic uremic patients undergoing periodical dialysis |
| 09/26/2002 | US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example |
| 09/26/2002 | US20020137942 HIV protease inhibitors; administering to treat AIDS (acquired immune deficiency syndrome) |
| 09/26/2002 | US20020137941 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137937 Process for preparing [S- (R*, S*) ] -beta- [ [ [1- [1-oxo-3- (4-piperidinyl) propyl] -3-piperidinyl] carbonyl]amino] -3-pyridinepropanoic acid and derivatives |
| 09/26/2002 | US20020137933 Heterocyclic sulfonamides |
| 09/26/2002 | US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma |
| 09/26/2002 | US20020137928 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 09/26/2002 | US20020137923 Per-(3,6-anhydro)cyclodextrins derivatives, preparation and use thereof for separating ions |
| 09/26/2002 | US20020137921 Oligonucleotides having chiral phosphorus linkages |
| 09/26/2002 | US20020137903 Sodium dependent glucose transporters found in the intestine and kidney (SGLT2); treating diabetes |
| 09/26/2002 | US20020137802 Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| 09/26/2002 | US20020137801 Administering gossypol; kits to treat patients |
| 09/26/2002 | US20020137800 2-cyclopenten-1-one and its derivatives as inhibitors of the NF-kB factor |
| 09/26/2002 | US20020137799 Sensitizing tumor cells with terpene such as perillyl alcohol |
| 09/26/2002 | US20020137798 Treatment of disorders secondary to organic impairments |
| 09/26/2002 | US20020137797 Alpha-Difluoromethylornithine (DFMO) suppresses polyamine levels in the human prostate |
| 09/26/2002 | US20020137796 Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants |
| 09/26/2002 | US20020137793 Stimulate mucin production in human conjuctival epithelium by applying topically |
| 09/26/2002 | US20020137792 Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes |